Category: Research-2024

Gamm Lab Discoveries Culminate in FDA Approval of a Clinical Trial for the Treatment of Inherited Photoreceptor Diseases

BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, an investigational induced pluripotent stem cell (iPSC)-based cell therapy for the treatment of primary photoreceptor diseases. Discoveries over the past …

Gamm lab Discoveries Culminate in FDA Approval of a Clinical Trial for the Treatment of Inherited Photoreceptor Diseases

  BlueRock Therapeutics LP, a clinical stage cell therapy company and subsidiary of Bayer AG, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for OpCT-001, an investigational induced pluripotent stem cell (iPSC)-based cell therapy for the treatment of primary photoreceptor diseases. Discoveries over the …

Testing senses and motor skills in midlife may help predict later cognitive impairment

When researchers test motor skills, hearing, vision and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health. A research team, led by senior …

Bassam Z. Shakhashiri Public Science Engagement Awards given for the second year

Congratulations to the winners of our 2023 Walsh Graduate Student Support Initiative Award!

It is our pleasure to announce the recipients of our 2023 David G. Walsh Graduate Student Support Initiative (GSSI) Award! Made possible by the David G. Walsh Research Fellowship Endowment Fund, GSSI provides McPherson ERI members 1-year grants of $12,000 to support the work of a graduate student. This year’s award recipients are Professor Gillian McLellan (Ophthalmology & …

Congratulations to the winners of our 2023 Distinguished Paper Award!

 It is our pleasure to announce the recipients of our 2023 Distinguished Paper Award. This year, the McPherson ERI honored 5 trainees for their outstanding, published vision research. This year’s winners will be recognized during a short ceremony at our upcoming 2024 MERI-at-a-Glance event (Friday, February 23rd). Further information on them and their papers can be found here.

Dr. Freya Mowat’s research featured in UW News

Freya Mowat Ever wonder what kind of TV shows your dog might choose if they could work the remote control? If so, check out this UW–Madison News article on McPherson ERI Member Freya Mowat’s research on canine vision. Prof. Mowat’s study, which began 2 years ago, focuses on uncovering the factors influencing dogs’ interest in interacting with …

Congratulations to the recipients of our 2023 AMD, RP, and Glaucoma & Optic Neuropathies Awards!

 It is our pleasure to announce the recipients of our second Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) Awards competition, as well as the recipient of our very first Glaucoma and Optic Neuropathies Award competition. This year, Prof. Nader Sheibani and Assistant Prof. Ismail Zaitoun have won our two AMD Awards, Prof. Kimberly Stepien has won the RP Award, and Prof. Rob Nickells has won the …

UW News features new research by MERI member Anjon Audhya and his team

Coat Protein Complex II (COPII) is an enormously important protein that is responsible for transporting approximately one third of all proteins that function in mammalian cells. In a recently published paper in Nature Communication, the Audhya team describes how, using genome editing and live cell imaging, they were able to identify that a single protein called Sec23 …